(NASDAQ: AADI) Aadi Bioscience's forecast annual revenue growth rate of 0.47% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 49.9%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.74%.
Aadi Bioscience's revenue in 2025 is $25,070,000.On average, 2 Wall Street analysts forecast AADI's revenue for 2025 to be $1,598,383,371, with the lowest AADI revenue forecast at $732,027,542, and the highest AADI revenue forecast at $2,464,739,200. On average, 1 Wall Street analysts forecast AADI's revenue for 2026 to be $736,957,021, with the lowest AADI revenue forecast at $736,957,021, and the highest AADI revenue forecast at $736,957,021.
In 2027, AADI is forecast to generate $793,646,022 in revenue, with the lowest revenue forecast at $793,646,022 and the highest revenue forecast at $793,646,022.